- Series: Atopic Dermatitis
- Expires: September 1, 2023
- Credit: .75hr(s)
- CME
- Therapeutic Areas: Allergy, Dermatology
- Specialties: Atopic Dermatitis
- On-Demand
Episode 1 of 3: What You Need to Know About New Targeted Therapies for AD
- Part of the Series: Atopic Dermatitis
- Available: April 22, 2022 —
- September 1, 2023
- Credit: 0.75hr(s)
- Credit Types: CME
- Therapeutic Areas: Allergy, Dermatology
- Specialties: Atopic Dermatitis
- Location: Internet Enduring Activity
Course Description
In episode 1 of the 3-part educational initiative TRANSFORMING TARGETED THERAPY IN ATOPIC DERMATITIS: APPLYING EMERGING DATA AND EVOLVING BEST PRACTICES TO IMPROVE OUTCOMES, dermatologists and allergists discuss what practicing clinicians need to know about newly approved oral JAK inhibitors. This activity focuses on the mechanism of action of novel targeted agents, their key safety and efficacy data, and their role in the treatment paradigm for atopic dermatitis.
Other Courses in this Series
- Series: Atopic Dermatitis
- Expires: September 1, 2023
- Credit: .75hr(s)
- CME
- Therapeutic Areas: Allergy, Dermatology
- Specialties: Atopic Dermatitis
Other Courses That May be of Interest
- Series: Atopic Dermatitis
- Expires: September 1, 2023
- Credit: .75hr(s)
- CME
- Therapeutic Areas: Allergy, Dermatology
- Specialties: Atopic Dermatitis
- Series: Atopic Dermatitis
- Expires: September 1, 2023
- Credit: .75hr(s)
- CME
- Therapeutic Areas: Allergy, Dermatology
- Specialties: Atopic Dermatitis
- Series: GVHD
- Expires: December 8, 2023
- Credit: 1.0hr(s)
- Therapeutic Areas: Dermatology, Family Medicine / Primary Care, Internal Medicine, Rheumatology
- Specialties: Primary Care